Your browser doesn't support javascript.
loading
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Fidler, Sarah; Fox, Julie; Tipoe, Timothy; Longet, Stephanie; Tipton, Tom; Abeywickrema, Movin; Adele, Sandra; Alagaratnam, Jasmini; Ali, Mohammad; Aley, Parvinder K; Aslam, Suhail; Balasubramanian, Anbhu; Bara, Anna; Bawa, Tanveer; Brown, Anthony; Brown, Helen; Cappuccini, Federica; Davies, Sophie; Fowler, Jamie; Godfrey, Leila; Goodman, Anna L; Hilario, Kathrine; Hackstein, Carl-Philipp; Mathew, Moncy; Mujadidi, Yama F; Packham, Alice; Petersen, Claire; Plested, Emma; Pollock, Katrina M; Ramasamy, Maheshi N; Robinson, Hannah; Robinson, Nicola; Rongkard, Patpong; Sanders, Helen; Serafimova, Teona; Spence, Niamh; Waters, Anele; Woods, Danielle; Zacharopoulou, Panagiota; Barnes, Eleanor; Dunachie, Susanna; Goulder, Philip; Klenerman, Paul; Winston, Alan; Hill, Adrian V S; Gilbert, Sarah C; Carroll, Miles; Pollard, Andrew J; Lambe, Teresa; Ogbe, Ane.
Afiliación
  • Fidler S; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Fox J; Department of HIV Medicine, St Mary's Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
  • Tipoe T; National Institute for Health and Care Research (NIHR) Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, United Kingdom.
  • Longet S; NIHR Guy's and St Thomas' Biomedical Research Centre, London, United Kingdom.
  • Tipton T; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Abeywickrema M; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Adele S; Nuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Alagaratnam J; Nuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Ali M; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Aley PK; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Aslam S; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Balasubramanian A; Department of HIV Medicine, St Mary's Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
  • Bara A; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Bawa T; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, United Kingdom.
  • Brown A; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Brown H; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Cappuccini F; National Institute for Health and Care Research (NIHR) Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, United Kingdom.
  • Davies S; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Fowler J; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Godfrey L; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Goodman AL; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Hilario K; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Hackstein CP; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Mathew M; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Mujadidi YF; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Packham A; Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom.
  • Petersen C; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Plested E; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Pollock KM; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Ramasamy MN; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Robinson H; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Robinson N; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Rongkard P; Department of HIV Medicine, St Mary's Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
  • Sanders H; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Serafimova T; National Institute for Health and Care Research (NIHR) Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, United Kingdom.
  • Spence N; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, United Kingdom.
  • Waters A; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Woods D; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, United Kingdom.
  • Zacharopoulou P; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Barnes E; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
  • Dunachie S; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Goulder P; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Klenerman P; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Winston A; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Hill AVS; Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, United Kingdom.
  • Gilbert SC; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Carroll M; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Pollard AJ; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
  • Lambe T; Department of HIV Medicine, St Mary's Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
  • Ogbe A; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Clin Infect Dis ; 76(2): 201-209, 2023 01 13.
Article en En | MEDLINE | ID: mdl-36196614
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_medicamentos_vacinas_tecnologias / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Infecciones por VIH / COVID-19 Límite: Adult / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_medicamentos_vacinas_tecnologias / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Infecciones por VIH / COVID-19 Límite: Adult / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido